227 related articles for article (PubMed ID: 25583841)
1. Subclinical central inflammation is risk for RIS and CIS conversion to MS.
Rossi S; Motta C; Studer V; Macchiarulo G; Germani G; Finardi A; Furlan R; Martino G; Centonze D
Mult Scler; 2015 Oct; 21(11):1443-52. PubMed ID: 25583841
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.
Thouvenot E; Hinsinger G; Demattei C; Uygunoglu U; Castelnovo G; Pittion-Vouyovitch S; Okuda D; Kantarci O; Pelletier D; Lehmann S; Marin P; Siva A; Lebrun C
Mult Scler; 2019 Apr; 25(5):669-677. PubMed ID: 29564952
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
Klíčová K; Mareš J; Sobek O; Rous Z; Rous M; Raška M; Hartung HP
Eur J Neurosci; 2024 Jun; 59(11):2955-2966. PubMed ID: 38453679
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
Lebrun C; Cohen M; Pignolet B; Seitz-Polski B; Bucciarelli F; Benzaken S; Kantarci O; Siva A; Okuda D; Pelletier D; Brassat D; ;
J Neurol Sci; 2016 Sep; 368():334-6. PubMed ID: 27538659
[TBL] [Abstract][Full Text] [Related]
6. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
[TBL] [Abstract][Full Text] [Related]
7. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.
Stampanoni Bassi M; Iezzi E; Landi D; Monteleone F; Gilio L; Simonelli I; Musella A; Mandolesi G; De Vito F; Furlan R; Finardi A; Marfia GA; Centonze D; Buttari F
J Neurol; 2018 Nov; 265(11):2540-2547. PubMed ID: 30167879
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis.
Sellebjerg F; Royen L; Soelberg Sørensen P; Oturai AB; Jensen PEH
Mult Scler; 2019 Oct; 25(11):1444-1451. PubMed ID: 30113249
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
Eur J Neurol; 2017 May; 24(5):703-712. PubMed ID: 28261960
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Wullschleger A; Kapina V; Molnarfi N; Courvoisier DS; Seebach JD; Santiago-Raber ML; Hochstrasser DF; Lalive PH
PLoS One; 2013; 8(8):e72399. PubMed ID: 24015240
[TBL] [Abstract][Full Text] [Related]
13. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
Kleine TO; Zwerenz P; Graser C; Zöfel P
Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
[TBL] [Abstract][Full Text] [Related]
14. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Calabrese M; Federle L; Bernardi V; Rinaldi F; Favaretto A; Varagnolo MC; Perini P; Plebani M; Gallo P
Mult Scler; 2012 Feb; 18(2):174-80. PubMed ID: 21868488
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.
Bielekova B; Komori M; Xu Q; Reich DS; Wu T
PLoS One; 2012; 7(11):e48370. PubMed ID: 23226202
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
Fissolo N; Cervera-Carles L; Villar Guimerans LM; Lleó A; Clarimón J; Drulovic J; Dujmovic I; Voortman M; Khalil M; Gil E; Navarro L; Álvarez-Cermeño JC; Montalban X; Comabella M
Mult Scler; 2019 Oct; 25(11):1535-1538. PubMed ID: 29985092
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
[TBL] [Abstract][Full Text] [Related]
18. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.
Rossi S; Motta C; Studer V; Rocchi C; Macchiarulo G; Barbieri F; Marfia G; Furlan R; Martino G; Mancino R; Centonze D
Mult Scler; 2014 Dec; 20(14):1841-50. PubMed ID: 24876157
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
